Johnson & Johnson at Cowen Health Care Conference Transcript

Mar 07, 2023 / 04:10PM GMT
Joshua Thomas Jennings - TD Cowen, Research Division - MD & Senior Research Analyst

Okay. Good morning. I'm Josh Jennings, Cowen Medical Devices team. We're moving right through the medical devices track, but we are incorporating some medical device part of a consumer hybrid into this track. And thankfully, with the executive team from Johnson & Johnson, we have Executive Vice President and Chief Financial Officer, Joe Wolk; and Vice President of Investor Relations, Jessica Moore. Joe, Jessica. Josh, we got 3 Js up here. Can't lose. Can't lose.

Thank you guys for participating in Cowen Healthcare -- TD Cowen Healthcare Conference, and great to see you in person.

Joseph J. Wolk - Johnson & Johnson - Executive VP & CFO

Same here. Thanks, Josh, for having us.

Questions and Answers:

Joshua Thomas Jennings - TD Cowen, Research Division - MD & Senior Research Analyst

Maybe to start, I just wanted to talk about some of the headwinds. I know Johnson & Johnson reports first, at least in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot